These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 9501091)

  • 21. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
    Zimber-Strobl U; Kempkes B; Marschall G; Zeidler R; Van Kooten C; Banchereau J; Bornkamm GW; Hammerschmidt W
    EMBO J; 1996 Dec; 15(24):7070-8. PubMed ID: 9003782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
    D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
    J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
    Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
    Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Signal transduction and biological characteristics of EB virus-encoded latent membrane protein 1 and its correlation with CD40].
    Tao Y; Zhang XG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):585-90. PubMed ID: 15562778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus.
    Kutz H; Reisbach G; Schultheiss U; Kieser A
    Virology; 2008 Feb; 371(2):246-56. PubMed ID: 17967471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
    Dudziak D; Kieser A; Dirmeier U; Nimmerjahn F; Berchtold S; Steinkasserer A; Marschall G; Hammerschmidt W; Laux G; Bornkamm GW
    J Virol; 2003 Aug; 77(15):8290-8. PubMed ID: 12857898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
    Busch LK; Bishop GA
    J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
    Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
    Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
    Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
    Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.
    Schultheiss U; Püschner S; Kremmer E; Mak TW; Engelmann H; Hammerschmidt W; Kieser A
    EMBO J; 2001 Oct; 20(20):5678-91. PubMed ID: 11598011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
    Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
    J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
    Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
    PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Epstein-Barr virus in neoplastic transformation.
    Knecht H; Berger C; Rothenberger S; Odermatt BF; Brousset P
    Oncology; 2001; 60(4):289-302. PubMed ID: 11408795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.